pharmaphorum

MARCH 21, 2019

Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab). The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market. Although there are only two drugs in this class available in the region – Eli Lilly’s Olumiant (baricitinib) and Pfizer’s Xeljanz (tofacitinib) – this is not likely to be th

Biosimilars 52

Biosimilars 52

RxNotes

MARCH 17, 2019

March is Pharmacist Awareness Month (PAM), a time to celebrate the contributions that pharmacists make to the Canadian healthcare system. PAM also provides a key opportunity for us to educate the public on the valuable services we deliver. “I didn’t know pharmacists could do that!

52

52

Med Ed 101

MARCH 20, 2019

Prerenal acute kidney injury is absolutely something that happens in real life practice. One of the reasons that this is something that is seen on a somewhat regular basis is that the drugs that can cause prerenal acute kidney injury are very common. Diuretics, Diuretics, Diuretics Any medication that can promote the loss of fluid […]. The post Prerenal Acute Kidney Injury – Must Know Drugs appeared first on Med Ed 101.

40

40

Pharma Packaging Solutions

MARCH 19, 2019

We are in the Lotte Palace at 455 Madison Avenue in Suite 5009 (same suite as last year). We are ready to discuss challenging packaging issues, upcoming serialization and aggregation deadlines, and more. Tank you for your continued interest and support of us. We look forward to 2019 challenges and working on them with you. The post Happy To Be at #DCATWeek19!

Packaging 40

Packaging 40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

MARCH 17, 2019

Most often, breathing difficulties are due to a chronic disease process like asthma or COPD. These are obvious possible diagnoses for any patient presenting with respiratory concerns. If you are a healthcare professional, you must recognize that there are a significant number of medications that may cause breathing difficulties. Here’s a list of a few […].

40

40